HAE Haemonetics
$103.52 -1.11%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-1.11%
YTD
+110.20%
P/E
49.6
P/B
3.21
ROE
11.3%
Div yield
—
Beta
0.08
Market cap
$4.8B
RSI (14)
49
Next earnings
Nov 4, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$104.92
Close
$103.52
VWAP (n/a)
—
Day high
$105.58
Day low
$102.80
Volume
542K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
PAHC vs. HAE: Which Stock Is the Better Value Option?
Yahoo Finance · Oct 5
Haemonetics (HAE) Could Be 66% Undervalued After Margin Expansion Focus
Yahoo Finance · Sep 22
PAHC vs. HAE: Which Stock Should Value Investors Buy Now?
Yahoo Finance · Sep 18
HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today?
Yahoo Finance · Sep 17
Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics
Yahoo Finance · Sep 15
GEHC vs. HAE: Which Stock Is the Better Value Option?
Yahoo Finance · Aug 31
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Aug 18, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 6, 2026 View → 8-K Jul 28, 2026 View → 8-K Jun 5, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell HAE. Try it in the Lab to size a position and see the risk.